OLAPLEX HOLDINGS DL-,001 Aktie

Olaplex shares climbed to a 52-week high of $2.04, driven by a strong YTD gain of 51% and a 12-month increase of 75%. Henkel is offering a cash takeover of $1.4bn ($2.06 per share), which represents a premium to the trading price. Olaplex reported mixed Q4 results with a mild EPS surprise but declining revenue; gross margins, however, improved. Analysts such as Morgan Stanley and Evercore cut or reaffirmed price targets citing challenges in growth, social media dynamics and e-commerce, and the stock remains volatile (beta ~2.0). » More on de.investing.com

Olaplex shares rose to a 52-week high of $2.02 while InvestingPro values the fair price at $1.50. Henkel announced a cash acquisition of Olaplex for $1.4 billion; shareholders are to receive $2.06 per share. In the last quarter Olaplex beat on EBITDA but slightly missed on revenue, and gross margin was above expectations. Analysts responded with downgraded price targets and ratings; Morgan Stanley rates it “Equalweight” with a $1.40 price target. » More on de.investing.com

Olaplex has seen its stock fall nearly 95% since its 2021 IPO after weakened demand, regulatory challenges and a 2023 lawsuit alleging hair damage that was later dismissed but hurt the brand. Fiscal 2023 U.S. net sales plunged 47.8% and net income fell 74.8%, while full-year 2025 sales were essentially flat despite a 4.3% Q4 increase. New CEO Amanda Baldwin is refocusing the brand with product innovation and marketing changes, but analysts remain cautious as competition and damaged perception pose ongoing headwinds; takeover interest from Henkel briefly lifted the stock. » More on cnbc.com

Olaplex reported Q4 2025 net revenue of $105.1m (+4.3% YoY) and fiscal-year sales of $423.0m, marking a stabilization after prior declines. Strong performance in the professional and D2C channels contrasted with declining specialty retail. Despite an improved gross margin, higher SG&A (from $52.9m to $65.1m) pressured the net result, producing a quarterly loss of $13.1m and reducing adjusted EBITDA and margins. The company significantly reduced long-term liabilities but also lowered cash balances, and announced 2026 revenue guidance of $414–435m along with increased investment in the “Bonds and Beyond” strategy. Investors reacted negatively: the stock fell sharply premarket due to higher costs, compressed margins and a cautious outlook. » More on de.investing.com

Olaplex shares jumped about 23% after a Bloomberg report about a possible takeover proposal from Henkel and trading was halted due to high volatility. According to the report, Olaplex and Henkel are in talks that could lead to a transaction within a few weeks, but no final decision has been made. Advent International remains the largest shareholder with around 75%; Olaplex has lost more than 90% of its market value since its IPO. » More on de.investing.com